Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > Medicago to get 173m in funding from Canada Gov
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Biotech010on Oct 23, 2020 3:55pm
245 Views
Post# 31772558

RE:RE:Medicago to get 173m in funding from Canada Gov

RE:RE:Medicago to get 173m in funding from Canada GovIMV needs to get those preclinical results out.... skip the scientific journal... Investors want returns... but managements wants to do the whole process the right way. I think that IMV is also in talks with HC. Because HC always stated that they will use different vaccines. This stock is a steal at this level!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities